US Nuclear Corp (UCLE)

US Nuclear Corp (OTC: UCLE) is a common stock listing on OTC Markets for US Nuclear Corp., a company that develops, manufactures, and sells radiation detection and measuring equipment worldwide. Through its Optron and Overhoff segments, the company provides a range of monitoring products, including radiation water monitors, alpha, beta, gamma, neutron, and tritium monitors, DroneRAD aerial detection systems, air and water monitors, nano-second X-ray monitors, vehicle and personnel monitors, radon products, handheld survey meters, dosimeters, pocket micro-R meters, and port security equipment. It also supplies software designed to track radiation levels and related environmental and facility conditions. US Nuclear Corp. serves customers in nuclear reactor plants, universities, hospitals, government agencies, emergency responders, airports, cargo and border screening operations, and other critical infrastructure settings. The company is headquartered in Canoga Park, California, and has a strategic alliance with Arbok-Nuclear focused on desalination and rad-wastewater treatment techniques.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-UCLE
$0.026
19.5% Upside
Undervalued
Not available
Not available
Weak
0.0%
November 27, 2026
0.6x
1.382 M
2.164 M
39.9%
75.7%
-20.5
-2.4%
13.5%
Valuation • Fair Value

US Nuclear Corp (OTC-UCLE) Fair Value by Valuation Model

Review the available estimates for US Nuclear Corp (OTC-UCLE), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.026

Estimated upside of 19.5% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.021

Discounted cash flow valuation reference.

Comps Fair Value

$0.029

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for US Nuclear Corp (OTC-UCLE) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for US Nuclear Corp (OTC-UCLE)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.169 M

Current operating scale indicator.

Revenue Forecast

2.169 M

Forward revenue estimate.

EBITDA

-807.485 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review US Nuclear Corp (OTC-UCLE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for US Nuclear Corp (OTC-UCLE)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-5.93

No elevated caution signal from this screen.

Altman Z-Score

-20.5

Lower score that deserves closer risk review.

FCF / Net Income

13.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for US Nuclear Corp (OTC-UCLE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for US Nuclear Corp (OTC-UCLE)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 27, 2026

Days to Earnings

66

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

-2.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for US Nuclear Corp (OTC-UCLE), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for US Nuclear Corp (OTC-UCLE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

US Nuclear Corp (OTC-UCLE) Stock FAQ

Data-supported answers about US Nuclear Corp (OTC-UCLE), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.026
Estimated upside 19.5%
Valuation Rating
Undervalued
Estimated upside of 19.5%
Financial Health
Weak
Current financial-health read

The current fair value estimate for US Nuclear Corp (OTC-UCLE) is $0.026. This implies an estimated upside of 19.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 19.5% versus the current market price.

The current financial health read for US Nuclear Corp (OTC-UCLE) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for US Nuclear Corp (OTC-UCLE) is November 27, 2026.

The latest available data indicates no current dividend yield for US Nuclear Corp (OTC-UCLE).

The current market capitalization listed for US Nuclear Corp is 1.382 M.

The current enterprise value listed for US Nuclear Corp is 2.164 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for US Nuclear Corp is OTC-UCLE, and the stock is listed on OTC Markets.

US Nuclear Corp (OTC-UCLE) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for US Nuclear Corp is 39.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for US Nuclear Corp is 75.7%. Free float helps investors understand how much of the share base is available for public trading.